Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme-Reference-Cited by-同舟云学术

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme

Author:

Hu Jiemiao¹^ORCID,Zhao Qingnan¹,Kong Ling-Yuan²,Wang Jian³^ORCID,Yan Jun¹,Xia Xueqing¹,Jia Zhiliang¹,Heimberger Amy B.²^ORCID,Li Shulin¹^ORCID

Affiliation:

1. Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

2. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Abstract

CXCL1/2, elevated in GBM to promote tumor progression, hold potential as clinical targets in GBM treatment.

Funder

National Institutes of Health

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference54 articles.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献